Fatpipe Inc/UT
FATN Nasdaq Services-Prepackaged Software Financials FY2024βFY2026
What Fatpipe Inc/UT does
No business description yet.
- Legal name
- Fatpipe Inc/UT
- Fiscal year ends
- March 31, 2026
- Latest annual report
- 10-K Β· May 18, 2026
- Accession Β· CIK
- 0001493152-26-024184
0001993400
Revenue and margins
Fatpipe Inc/UT had $19.2M of revenue in fiscal 2026, up 17.9% on the year before.
Net income and earnings per share
From fiscal 2024 to 2026, diluted EPS grew 0.0% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$0.8M in fiscal 2026, β4.3% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Fatpipe Inc/UT returned β to shareholders in fiscal 2026. The diluted share count rose 8.9%.
Balance sheet
Cash, debt and the ratios that show how comfortably Fatpipe Inc/UT can carry it.
| Fiscal year end | FY24 | FY25 | FY26 |
|---|---|---|---|
| Cash and short-term investments | $1.1M | $2.9M | $5.2M |
| Debt incl. finance leases | β | $5.0M | $4.6M |
| Net debt / EBITDA | β | 0.5x | β0.1x |
| Debt / equity | β | 0.3x | 0.2x |
| Interest coverage | 18.7x | 10.5x | 8.9x |
| Current ratio | 2.0x | 2.0x | 3.9x |
| Quick ratio | 2.0x | 1.9x | 3.7x |
| Total assets | $21.4M | $28.3M | $34.5M |
| Total liabilities | $7.4M | $12.4M | $9.3M |
| Shareholders' equity | $13.9M | $15.9M | $25.2M |
| Net debt (β = net cash) | β | $2.1M | β$0.6M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY24 | FY25 | FY26 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | 2 / 8 | 4 / 9 |
| Accruals ratio | 22.1% | 9.9% | 18.3% |
| Altman Z'' | 6.54 | 4.96 | 7.38 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY24 | FY25 | FY26 |
|---|---|---|---|
| Income statement | |||
| Revenue | $17.9M | $16.3M | $19.2M |
| Gross profit | $16.8M | $15.2M | $17.5M |
| Research and development | β | $1.8M | $1.9M |
| Operating income | $5.6M | $3.5M | $3.6M |
| Interest expense | $0.3M | $0.3M | $0.4M |
| Pretax income | $5.6M | $3.3M | $3.5M |
| Income tax | $1.4M | $1.3M | β$1.5M |
| Net income | $4.4M | $2.0M | $5.0M |
| Net income to common | β | $2.0M | $5.0M |
| Diluted EPS | $0.35 | $0.15 | $0.35 |
| Diluted shares | 0.01B | 0.01B | 0.01B |
| Cash flow | |||
| Cash from operations | β$0.4M | β$0.5M | β$0.8M |
| Capital expenditure | $0.0M | $0.0M | $0.1M |
| Free cash flow | β$0.4M | β$0.5M | β$0.8M |
| Depreciation and amortization | $0.7M | $0.5M | $0.4M |
| Stock-based compensation | β | β | $0.8M |
| Balance sheet | |||
| Cash and short-term investments | $1.1M | $2.9M | $5.2M |
| Total debt | β | $5.0M | $4.6M |
| Current assets | $9.3M | $13.0M | $16.5M |
| Current liabilities | $4.7M | $6.5M | $4.3M |
| Inventory | $0.1M | $0.4M | $0.4M |
| Property and equipment, net | $0.1M | $0.1M | $0.1M |
| Intangible assets | $1.6M | $1.0M | $0.7M |
| Total assets | $21.4M | $28.3M | $34.5M |
| Total liabilities | $7.4M | $12.4M | $9.3M |
| Shareholders' equity | $13.9M | $15.9M | $25.2M |
| Margins | |||
| Gross margin | 94.0% | 93.5% | 91.0% |
| Operating margin | 31.6% | 21.3% | 18.7% |
| EBITDA margin | 35.5% | 24.7% | 20.6% |
| Net margin | 24.4% | 12.1% | 25.9% |
| FCF margin | β2.1% | β3.2% | β4.3% |
| Returns | |||
| Return on capital | β | 12.5% | 14.6% |
| Return on capital employed | 33.7% | 15.9% | 11.9% |
| Return on equity | 31.3% | 13.2% | 24.2% |
| Return on assets | 20.4% | 7.9% | 15.8% |
| Return on tangible equity | 35.3% | 13.2% | 20.3% |
| Growth | |||
| Revenue growth | β | β8.8% | 17.9% |
| Net income growth | β | β55.0% | 152.7% |
| EPS growth | β | β57.1% | 133.3% |
| Share count change | β | 3.3% | 8.9% |
| Financial health | |||
| Net debt / EBITDA | β | 0.5x | β0.1x |
| Debt / equity | β | 0.3x | 0.2x |
| Interest coverage | 18.7x | 10.5x | 8.9x |
| Current ratio | 2.0x | 2.0x | 3.9x |
| Quick ratio | 2.0x | 1.9x | 3.7x |
| Capital allocation | |||
| Capex / revenue | 0.1% | 0.1% | 0.3% |
| Stock comp / revenue | β | β | 4.0% |
| Quality scores | |||
| Piotroski F-score | β | 2.0 | 4.0 |
| Altman Z'' | 6.5 | 5.0 | 7.4 |
| Accruals ratio | 22.1% | 9.9% | 18.3% |
Source: SEC EDGAR XBRL filings (CIK 0001993400). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.